PETAL: a global view on R/R T-/NK-lymphoma treatment reality.
作者信息
Jiang Qu, Herling Marco
机构信息
Department for Hematology, Cellular Therapy, Hemostaseology, and Infectious Diseases, University Hospital of Leipzig, Leipzig, Germany.
Cancer Center Central Germany, Leipzig-Jena, Leipzig University Hospital, Leipzig, Germany.
出版信息
Blood Adv. 2025 Feb 11;9(3):642-643. doi: 10.1182/bloodadvances.2024015156.
Abstract
摘要
相似文献
1
PETAL: a global view on R/R T-/NK-lymphoma treatment reality.PETAL：关于复发/难治性T/NK细胞淋巴瘤治疗现状的全球视角。
Blood Adv. 2025 Feb 11;9(3):642-643. doi: 10.1182/bloodadvances.2024015156.
2
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium.复发/难治性成熟T细胞和NK细胞淋巴瘤的全球结局与预后：PETAL联盟的结果
Blood Adv. 2025 Feb 11;9(3):583-602. doi: 10.1182/bloodadvances.2024014674.
3
[Pretreatment evaluation of F-FDG PET-CT in extranodal NK/T-cell lymphoma].[F-FDG PET-CT在结外NK/T细胞淋巴瘤中的预处理评估]
Zhonghua Zhong Liu Za Zhi. 2022 Apr 23;44(4):370-376. doi: 10.3760/cma.j.cn112152-20200525-00485.
4
Expression of Tryptophan Metabolism Enzymes in Patients with Diffuse Large B-cell Lymphoma and NK/T-cell Lymphoma.色氨酸代谢酶在弥漫性大 B 细胞淋巴瘤和 NK/T 细胞淋巴瘤患者中的表达。
Cancer Med. 2023 Jun;12(11):12139-12148. doi: 10.1002/cam4.5903. Epub 2023 May 6.
5
The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.基于抗PD-1抗体的治疗方案在结外NK/T细胞淋巴瘤相关噬血细胞性淋巴组织细胞增生症治疗中的新兴作用。
J Cancer Res Clin Oncol. 2023 May;149(5):2017-2027. doi: 10.1007/s00432-022-04147-2. Epub 2022 Jul 9.
6
Forecasting optimal treatments in relapsed/refractory mature T- and NK-cell lymphomas: A global PETAL Consortium study.预测复发/难治性成熟T细胞和NK细胞淋巴瘤的最佳治疗方案：一项全球PETAL联盟研究。
Br J Haematol. 2025 Jun;206(6):1664-1677. doi: 10.1111/bjh.20063. Epub 2025 May 1.
7
8
[Expression and its significance of STAT3, STAT5, Survivin and Ki67 in nasal NK/T cell lymphoma].[信号转导和转录激活因子3、信号转导和转录激活因子5、生存素及Ki67在鼻NK/T细胞淋巴瘤中的表达及其意义]
Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2006 Oct;20(20):931-3, 936.
9
Presentation of two cases of nasal type NK/T-cell lymphoma.两例鼻型NK/T细胞淋巴瘤病例报告
Eur Arch Otorhinolaryngol. 2007 Jan;264(1):39-43. doi: 10.1007/s00405-006-0194-8. Epub 2006 Nov 3.
10
Mosquito Bite-Induced Localized NK/T-Cell Lymphoma Relapsed in a Patient with Complete Remission of Extranodal NK/T-Cell Lymphoma, Nasal Type.蚊虫叮咬诱发的局限性NK/T细胞淋巴瘤在1例鼻型结外NK/T细胞淋巴瘤完全缓解的患者中复发。
Case Rep Dermatol. 2019 Jun 26;11(2):194-197. doi: 10.1159/000501358. eCollection 2019 May-Aug.
本文引用的文献
1
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium.复发/难治性成熟T细胞和NK细胞淋巴瘤的全球结局与预后：PETAL联盟的结果
Blood Adv. 2025 Feb 11;9(3):583-602. doi: 10.1182/bloodadvances.2024014674.
2
Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma.复发/难治性外周 T 细胞淋巴瘤的新型临床风险分层和治疗策略。
J Hematol Oncol. 2024 Jun 1;17(1):38. doi: 10.1186/s13045-024-01560-7.
3
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry.复发外周 T 细胞淋巴瘤的治疗策略和结果：荷兰癌症登记处的结果。
Blood Adv. 2024 Jul 23;8(14):3619-3628. doi: 10.1182/bloodadvances.2023012531.
4
Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell Lymphomas.复发难治性外周T细胞淋巴瘤治疗的最新进展
J Pers Med. 2022 Jun 13;12(6):964. doi: 10.3390/jpm12060964.
5
The diagnosis and management of NK/T-cell lymphomas.NK/T细胞淋巴瘤的诊断与管理
J Hematol Oncol. 2017 Apr 14;10(1):85. doi: 10.1186/s13045-017-0452-9.
6
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.复发/难治性外周T细胞淋巴瘤（非特殊类型）和血管免疫母细胞性T细胞淋巴瘤患者的生存结局。
Br J Haematol. 2017 Mar;176(5):750-758. doi: 10.1111/bjh.14477. Epub 2016 Dec 16.
7
Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States.美国外周 T 细胞淋巴瘤发病率和生存率的种族模式。
J Clin Oncol. 2016 Mar 20;34(9):963-71. doi: 10.1200/JCO.2015.63.5540.
8
Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors.外周 T 细胞淋巴瘤患者首次复发或进展后的生存情况：疾病谱和罕见的长期幸存者。
J Clin Oncol. 2013 Jun 1;31(16):1970-6. doi: 10.1200/JCO.2012.44.7524. Epub 2013 Apr 22.
Zotero 插件